Cipla shares fall 7% after Pithampur unit gets 8 observations from USFDA

The US Food and Drug Administration (USFDA) conducted a current Good Manufacturing Practices (cGMP) inspection at the manufacturing facility from February 6-17, the Mumbai-based drug firm said in a regulatory filing on Saturday.

from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/MagYAso
>

Comments

Popular posts from this blog

China's video-game curbs shock stocks

Relief for lessors: Delhi high court directs DGCA to de-register 54 GoAir planes